ID: ALA376403

Max Phase: Preclinical

Molecular Formula: C41H74N12O11

Molecular Weight: 911.12

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O

Standard InChI:  InChI=1S/C41H74N12O11/c1-22(2)17-27(48-32(54)21-47-38(61)31-13-10-16-53(31)39(62)25(43)11-9-15-46-41(44)45)34(57)50-29(19-24(5)6)36(59)52-30(20-33(55)56)37(60)51-28(18-23(3)4)35(58)49-26(40(63)64)12-7-8-14-42/h22-31H,7-21,42-43H2,1-6H3,(H,47,61)(H,48,54)(H,49,58)(H,50,57)(H,51,60)(H,52,59)(H,55,56)(H,63,64)(H4,44,45,46)/t25-,26-,27-,28-,29-,30-,31-/m0/s1

Standard InChI Key:  ZMHOWEUHDSPZTF-XIJWKTHWSA-N

Associated Targets(non-human)

Hypothalamus (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 911.12Molecular Weight (Monoisotopic): 910.5600AlogP: -2.07#Rotatable Bonds: 30
Polar Surface Area: 383.45Molecular Species: ZWITTERIONHBA: 12HBD: 13
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 16#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.72CX Basic pKa: 11.56CX LogP: -6.51CX LogD: -6.98
Aromatic Rings: 0Heavy Atoms: 64QED Weighted: 0.02Np Likeness Score: 0.08

References

1. Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H..  (2007)  Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.,  50  (13): [PMID:17550241] [10.1021/jm0610548]

Source